The government can keep the impact assessment of its controversial US-UK drug trade deal secret, the Information Commissioner's Office has ruled, dismissing a complaint from the Nuffield Trust. Under the deal — struck in December 2025 to shield Britain from Trump's tariffs — the UK became the only country in the world with a 0% tariff on pharmaceutical exports to America. But the price of those preferential terms was steep: ministers agreed to a 25% rise in NICE's...